A randomized, double blind, single dose, comparative study of the pharmacokinetics, safety and immunogenicity of MB02 (bevacizumab biosimilar) and reference bevacizumab in healthy...

por Sinn, Angela, García‐Alvarado, Fernanda, Gonzalez, Veronica, Huerga, Camino, Bullo, Felicitas
Publicado 2021